Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

CAPS Rating: 2 out of 5

ICPT News and Commentary

Caps

How do you think ICPT will perform against the market?

Add Stock to CAPS Watchlist

All Players

75 Outperform
33 Underperform
 

All-Star Players

21 Outperform
8 Underperform
 

Wall Street

4 Outperform
2 Underperform
 

Top ICPT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Emjae06 (< 20)
Submitted January 11, 2014

Maybe it would continue to go up.

NewbiesRock (< 20)
Submitted February 18, 2014

I picked underperformed because the Intercept Molecule had some negative impact on cholesterol and it seems they didn't fix that problem yet. The FDA will probably want to look deeper into that. Furthermore another company that has a very good… More

ICPT VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ICPT.

Recs

0
Member Avatar XMFLurch (51.21) Submitted: 9/27/2017 4:32:35 PM : Outperform Start Price: $63.00 ICPT Score: +1.36

Oversold on fear of "black label". NASH play.

Recs

0
Member Avatar TMFang4apples (55.39) Submitted: 3/22/2017 1:49:07 PM : Outperform Start Price: $114.73 ICPT Score: -51.22

A less than ideal safety profile means it could easily succumb to competition further down the road, but Ocaliva is a clear frontrunner for the $30B NASH market. Based on phase 2 results, there's a good chance interim phase 3 data expected in 2019 will make this a double bagger or better. Glad to have it in my CAPS, if not in my personal retirement portfolio.

Recs

0
Member Avatar Hendrickson71 (< 20) Submitted: 12/15/2015 5:16:38 PM : Outperform Start Price: $164.01 ICPT Score: -84.11

This is a start of a rocket.

Leaderboard

Find the members with the highest scoring picks in ICPT.

Score Leader

alkusari

alkusari (< 20) Score: +443.87

The Score Leader is the player with the highest score across all their picks in ICPT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
vzwatmrk < 20 1/10/2014 Underperform 5Y $455.50 -85.60% +39.55% +125.15 0 Comment
Halffrenzy 25.07 1/10/2014 Underperform 5Y $438.98 -85.06% +39.84% +124.89 0 Comment
jjc007007 64.70 2/5/2014 Underperform 5Y $296.00 -77.84% +45.94% +123.78 0 Comment
sinvestor 51.17 1/14/2014 Underperform 3M $361.00 -81.83% +40.50% +122.33 1 Comment
kevrose31 81.55 1/10/2014 Underperform 1Y $373.00 -82.41% +39.23% +121.64 0 Comment
NewbiesRock < 20 2/18/2014 Underperform 5Y $353.89 -81.46% +39.05% +120.51 4 Comments
alexeysm 74.94 1/13/2014 Underperform 1Y $339.87 -80.70% +39.41% +120.11 0 Comment
Figgie27 < 20 1/13/2014 Underperform 3M $339.87 -80.70% +39.41% +120.11 0 Comment
kayakmastr 93.59 1/13/2014 Underperform 1Y $339.87 -80.70% +39.41% +120.11 0 Comment
gillet01 78.70 4/7/2014 Underperform 5Y $298.86 -78.05% +38.53% +116.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.93 3/2/2016 Underperform 3W $119.37 -45.04% +28.70% +73.74 0 Comment
TrackRWBaird 90.27 12/4/2014 Outperform NS $139.99 -53.14% +23.40% -76.54 0 Comment
TrackFBRCapitalM 90.14 8/15/2014 Underperform NS $292.33 -77.56% +30.36% +107.92 0 Comment
TrackDeutscheSec 88.23 7/15/2014 Outperform NS $226.00 -70.97% +29.53% -100.51 0 Comment
TrackJimCramer 84.93 4/3/2014 Outperform 3W $321.81 -62.91% +5.50% -68.40 3/2/2016 @ $119.37 0 Comment
TrackCitigroup 93.28 3/14/2014 Outperform NS $467.00 -85.95% +38.59% -124.54 0 Comment
TrackJimCramer 84.93 1/9/2014 Underperform 3W $275.87 +16.65% +2.72% -13.94 4/3/2014 @ $321.81 0 Comment
TrackJanney 82.93 2/21/2013 Outperform NS $37.24 +76.15% +69.65% +6.50 0 Comment

Featured Broker Partners